Literature DB >> 8782823

The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas.

M R Gailani1, M Ståhle-Bäckdahl, D J Leffell, M Glynn, P G Zaphiropoulos, C Pressman, A B Undén, M Dean, D E Brash, A E Bale, R Toftgård.   

Abstract

Basal cell carcinoma (BCC) is the most common cancer in humans. The majority of sporadic BCCs have allele loss on chromosome 9q22 implying that inactivation of a tumour suppressor in this region is an important step in BCC formation. The gene for nevoid basal cell carcinoma syndrome (NBCCS), an autosomal dominant disorder characterized by multiple BCCs, maps to the same region and is presumed to be the tumour suppressor inactivated at this site. NBCCS has been identified recently and encodes a protein with strong homology to the Drosophila segment polarity gene, patched. Analysis of Drosophila mutants indicates that patched interacts with the hedgehog signalling pathway, repressing the expression of various hedgehog target genes including wingless, decapentaplegic and patched itself. Using single strand conformational polymorphism (SSCP) to screen human patched in 37 sporadic BCCs, we detected mutations in one-third of the tumours. Direct sequencing of two BCCs without SSCP variants revealed mutations in those tumours as well suggesting that inactivation of patched is probably a necessary step in BCC development. Northern blots and RNA in situ hybridization showed that patched is expressed at high levels in tumour cells but not normal skin suggesting that mutational inactivation of the gene leads to overexpression of mutant transcript owing to failure of a negative feedback mechanism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782823     DOI: 10.1038/ng0996-78

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  155 in total

1.  Mutations in the human homologue of the Drosophila segment polarity gene patched in oral squamous cell carcinoma cell lines.

Authors:  E Michimukai; N Kitamura; Y Zhang; H Wang; Y Hiraishi; K Sumi; Y Hayashido; S Toratani; T Okamoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001 Jul-Aug       Impact factor: 2.416

2.  Persistent p53 mutations in single cells from normal human skin.

Authors:  G Ling; A Persson; B Berne; M Uhlén; J Lundeberg; F Ponten
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 3.  Basal cell carcinoma.

Authors:  J T Lear; I Harvey; D de Berker; R C Strange; A A Fryer
Journal:  J R Soc Med       Date:  1998-11       Impact factor: 5.344

4.  Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions.

Authors:  Juliet A Williams; Oivin M Guicherit; Beatrice I Zaharian; Yin Xu; Ling Chai; Hynek Wichterle; Charlene Kon; Christine Gatchalian; Jeffery A Porter; Lee L Rubin; Frank Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

5.  High levels of patched gene mutations in basal-cell carcinomas from patients with xeroderma pigmentosum.

Authors:  N Bodak; S Queille; M F Avril; B Bouadjar; C Drougard; A Sarasin; L Daya-Grosjean
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

Review 6.  Basal cell carcinoma.

Authors:  C S M Wong; R C Strange; J T Lear
Journal:  BMJ       Date:  2003-10-04

7.  Mutations in ACTRT1 and its enhancer RNA elements lead to aberrant activation of Hedgehog signaling in inherited and sporadic basal cell carcinomas.

Authors:  Elodie Bal; Hyun-Sook Park; Zakia Belaid-Choucair; Hülya Kayserili; Magali Naville; Marine Madrange; Elena Chiticariu; Smail Hadj-Rabia; Nicolas Cagnard; Francois Kuonen; Daniel Bachmann; Marcel Huber; Cindy Le Gall; Francine Côté; Sylvain Hanein; Rasim Özgür Rosti; Ayca Dilruba Aslanger; Quinten Waisfisz; Christine Bodemer; Olivier Hermine; Fanny Morice-Picard; Bruno Labeille; Frédéric Caux; Juliette Mazereeuw-Hautier; Nicole Philip; Nicolas Levy; Alain Taieb; Marie-Françoise Avril; Denis J Headon; Gabor Gyapay; Thierry Magnaldo; Sylvie Fraitag; Hugues Roest Crollius; Pierre Vabres; Daniel Hohl; Arnold Munnich; Asma Smahi
Journal:  Nat Med       Date:  2017-09-04       Impact factor: 53.440

8.  Tumor Architecture and Notch Signaling Modulate Drug Response in Basal Cell Carcinoma.

Authors:  Markus Eberl; Doris Mangelberger; Jacob B Swanson; Monique E Verhaegen; Paul W Harms; Marcus L Frohm; Andrzej A Dlugosz; Sunny Y Wong
Journal:  Cancer Cell       Date:  2018-01-27       Impact factor: 31.743

Review 9.  Safety and Tolerability of Sonic Hedgehog Pathway Inhibitors in Cancer.

Authors:  Richard L Carpenter; Haimanti Ray
Journal:  Drug Saf       Date:  2019-02       Impact factor: 5.606

Review 10.  [Current diagnostics and therapy recommendations for ocular basal cell carcinoma].

Authors:  V Kakkassery; K U Loeffler; M Sand; K R Koch; A M Lentzsch; A C Nick; I A Adamietz; L M Heindl
Journal:  Ophthalmologe       Date:  2017-03       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.